FDA Oversight Of Clinical Trials: Changes Loom

Law360, New York (November 15, 2007, 12:00 AM EST) -- On Sept. 28, 2007, the Office of the Inspector General for the Department of Health and Human Services (OIG) released a report entitled "The Food and Drug Administration’s Oversight of Clinical Trials" (the Report).

The OIG issued the Report pursuant to a congressional request to review oversight of clinical trials by the U.S. Food and Drug Administration (FDA) after a series of news articles detailed vulnerabilities in enforcement and monitoring of clinical trials in humans (For example, see David Evans et al., Drug Industry Human Testing...
To view the full article, register now.